Green Cross Medical Science Corp operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross Medical Science Corp with three other
pharmaceutical manufacturers in Asia:
sales of 87.66 billion Korean Won [US$82.14 million]
Mizuho Medy Co Ltd
(5.62 billion Japanese Yen [US$52.76 million]
Nissui Pharmaceutical Co., Ltd.
based in Japan
(12.83 billion Japanese Yen [US$120.30 million]
of which 45%
Green Cross Medical Science Corp reported sales of 98.39 billion Korean Won (US$92.19 million)
December of 2017.
increase of 14.2%
versus 2016, when the company's sales were 86.16 billion Korean Won.